Decision Resources Group, a subsidiary of Piramal Enterprises, has acquired the U.K.-based Abacus International, a provider of evidence-based global market access solutions for many of the world’s leading healthcare companies for an unspecified amount.
Decision Resources Group, based in Burlington, Massachusetts (U.S.), is one of the world’s leading research and advisory firms focusing on healthcare insights and analysis. The acquisition of Abacus will result in a significant global expansion of Decision Resources Group’s market access capabilities, the company said.
Abacus will be part of the Market Access Business Unit at Decision Resources Group, which, at present, includes brands such as Fingertip Formulary, HealthLeaders-InterStudy, PharmaStrat and Pinsonault.
“Abacus brings to the table a unique combination of technical excellence and robust, evidence-based analysis resulting in solutions that are well-designed to address the needs of our healthcare clients,” said Jim Lang, President of the Market Access Business Unit at Decision Resources Group.
“Besides expanding our global market access services and products, the acquisition also allows us to now offer market access capabilities for the medical device and diagnostic industry as well as to significantly expand our commercial support capabilities, with industry-leading mobile communication tools,” he added.
“We view this acquisition as a major step towards becoming a fully integrated global market access solutions provider,” said Simon Howard, CEO of Abacus International.
“Abacus is an important acquisition in Decision Resources Group’s overall strategy to expand our market access capabilities, and offer our clients the most innovative, high-value advisory solutions,” said Peter Hoenigsberg, CEO of Decision Resources Group.
Abacus International will remain headquartered in Bicester, England.
